Graziella Soulban

Effects of Tesamorelin (TH9507), a Growth Hormone-Releasing Factor Analog, in Human Immunodeficiency Virus-Infected Patients with Excess Abdominal Fat: A Pooled Analysis of Two Multicenter, Double-Blind Placebo-Controlled Phase 3 Trials with Safety Extension Data

Julian Falutz, Jean‐Claude Mamputu, Diane Potvin et al. · The Journal of Clinical Endocrinology & Metabolism · 2010 · 95 citations

Medicine, Endocrinology, Pharmacotherapy +17

Efficacy and safety of ospemifene in postmenopausal women with moderate-to-severe vaginal dryness: a phase 3, randomized, double-blind, placebo-controlled, multicenter trial

David F. Archer, Steven R. Goldstein, James A. Simon et al. · Menopause The Journal of The North American Menopause Society · 2019 · 65 citations · Full text

Medicine, Pharmacology, Pharmacotherapy +13

Circadian rhythms of blood clotting time and coagulation factors II, VII, IX and X in rats

Graziella Soulban, Gaston Labrecque · Life Sciences · 1989 · 44 citations

Life Sciences, Hematology, Physiology +16

Reduction in Visceral Adiposity Is Associated With an Improved Metabolic Profile in HIV-Infected Patients Receiving Tesamorelin

Takara L. Stanley, Julian Falutz, Christian Marsolais et al. · Clinical Infectious Diseases · 2012 · 28 citations

Pharmacy, Endocrinology, Pharmacotherapy +17

Effects of ospemifene on genitourinary health assessed by prospective vulvar-vestibular photography and vaginal/vulvar health indices

Irwin Goldstein, James A. Simon, Andrew M. Kaunitz et al. · Menopause The Journal of The North American Menopause Society · 2019 · 28 citations · Full text

Medicine, Gynecology, Women's Health +15